Amalia Gastaldelli

ACN Board Member

Dr. Gastaldelli is the responsible of the Cardiometabolic Risk Laboratory at the Institute of Clinical Physiology (IFC) of CNR of Pisa, Italy (position first researcher, since 2010), and adjunct associate professor at the Division of Diabetes of University of Texas Health Science Center, in San Antonio, TX, USA (since 2006). In 2014 she received the National Habilitation for Full Professor in Endocrinology and for Associate Professor in Bioengineering (validity until 2020). She has more than 20 years experience in leading national and international scientific projects investigating metabolic diseases including obesity, non alcoholic fatty liver disease (NAFLD) and type 2 diabetes.

In 2011 she initiated and is currently the chair of the EASD NAFLD Study Group, which provides a joint forum for diabetologists and hepatologists to explore the diagnosis, pathogenesis and treatment of NAFLD and NASH. She was a member of the EASL-EASD-EASO committee for the “Clinical Practice Guidelines for the management of NAFLD” (published April 2016).

She has published more than 200 articles in international journals and book chapters with a global H index of 68 and more than 14,000 citations. She is also the associate editor of the Journal of the American College of Nutrition and reviewer for more the 25 international peer review journals. She has been an invited speaker in more than 70 national and international congresses and recently recognized among the top Italian women scientists for biomedical sciences.